Lucid Diagnostics Q3 Adj. EPS $(0.06), Inline, Sales $1.203M Miss $1.635M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Misses
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 40 percent increase over losses of $(0.10) per share from the same period last year.
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.203 million which missed the analyst consensus estimate of $1.635 million by 26.42 percent. This is a 0.66 percent decrease over sales of $1.211 million the same period last year.